Yuyu Pharma exceeds 50 million tablets collectively with Yuclid for the past 10 years

Yuyu Pharma(CEO In-Seok Choi) celebrated the 10-year anniversary of ‘Yuclid,’ a self-developed incrementally modified antiplatelet drug.

About 56,966,712 tablets or 661,750 units(30T, 300T) of Yuclid have been sold at the end of this May ever since its first launch on 1 September 2008. Since the size of 1 tablet of Yuclid is 10.6mm, it goes up to 614km if lining up all the Yuclid products sold...